Development of a test system and a method for detecting ribonucleic acid of severe acute respiratory syndrome coronavirus 2 using real-time polymerase chain reaction

Abstract

Given the rapid spread of coronavirus disease 2019 (COVID-19) globally, test systems are needed for its diagnosis, timely treatment, and introduction of quarantine measures. In the shortest possible time, a diagnostic system based on real-time reverse-transcription polymerase chain reaction to detect the ribonucleic acid of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal and oropharyngeal smears was developed and registered. The method determines the nucleocapsid and small-membrane protein genes and the human PGK1 gene, acting as internal control reactions. The nucleotide sequences of SARS-CoV-2 were analyzed, and primers were selected. The conditions for carrying out real-time reverse-transcription polymerase chain reaction and the composition of a set of reagents were set. The diagnostic sensitivity and specificity of the kit were tested on biological samples, with the addition of inactivated SARS-CoV-2. The high analytical characteristics of the developed set of reagents were demonstrated, with a sensitivity of at least 103 GE/mL and a specificity of 100%, and no false-positive or false-negative results were recorded. The high specificity of the test system was shown on a representative sample of genetic materials of respiratory viral pathogens. Clinical and laboratory tests of the diagnostic “SARS-CoV-2 test” were conducted in the N.F. Gamalei National Research Center for Epidemiology and Microbiology. A set of reagents for the detection of ribonucleic acid of SARS-CoV-2 through on real-time reverse-transcription polymerase chain reaction for in vitro diagnostics “SARS-CoV-2 test” was registered in the Russian Federation as a medical device (Registration certificate no. RZN 2020/10632, dated 06/03/2020).

Keywords

diagnostics of infectious diseases / molecular diagnostics / new coronavirus infection / reverse-transcription and polymerase chain reaction in real-time / coronavirus of severe acute respiratory syndrome-2 / genetic material / nucleocapsid / pathogens of respiratory viral infections

References

[1] Medunitsyn NV, Katlinsky AV, Vorslov LO. Editors. Vaccinology. Moscow: Practical Medicine; 2022. 480 p. (In Russ.)

[2] Вакцинология / под ред. Н.В. Медуницына, А.В. Катлинского, Л.О Ворслова. Москва: Практическая медицина, 2022. 480 с.

[3] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. DOI: 10.1056/NEJMoa2001316

[4] Li Q., Guan X., Wu P., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia // N Engl J Med. 2020. Vol. 382, No. 13. P. 1199–1207. DOI: 10.1056/NEJMoa2001316

[5] Wang H, Wang W, Tan W. Summary of the detection kits for SARS-CoV-2 approved by the National Medical Products Administration of China and their application for diagnosis of COVID-19. Virol Sin. 2020;35(6):699–712. DOI: 10.1007/s12250-020-00331-1

[6] Wang H., Wang W., Tan W. Summary of the detection kits for SARS-CoV-2 approved by the National Medical Products Administration of China and their application for diagnosis of COVID-19 // Virol Sin. 2020. Vol. 35, No. 6. P. 699–712. DOI: 10.1007/s12250-020-00331-1

[7] Park S, Zhang Y, Lin S, et al. Advances in microfluidic PCR for point-of-care infectious disease diagnostics. Biotechnol Adv. 2011;29(6):830–839. DOI: 10.1016/j.biotechadv.2011.06.017

[8] Park S., Zhang Y., Lin S., et al. Advances in microfluidic PCR for point-of-care infectious disease diagnostics // Biotechnol Adv. 2011. Vol. 29, No. 6. P. 830–839. DOI: 10.1016/j.biotechadv.2011.06.017

[9] Esbin MN, Whitney ON, Chong S, et al. Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection. RNA. 2020;26(7):771–783. DOI: 10.1261/rna.076232.120

[10] Esbin M.N., Whitney O.N., Chong S., et al. Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection // RNA. 2020. Vol. 26, No. 7. P. 771–783. DOI: 10.1261/rna.076232.120

[11] Tan W, Zhao X, Ma X. et al. A novel coronavirus genome Identified in a cluster of pneumonia cases. Wuhan, China 2019−2020. China CDC Weekly. 2020;2(4):61–62. DOI: 10.46234/ccdcw2020.017

[12] Tan W., Zhao X., Ma X., et al. A novel coronavirus genome Identified in a cluster of pneumonia cases. Wuhan, China 2019−2020 // China CDC Weekly. 2020. Vol. 2, No. 4. P. 61–62. DOI: 10.46234/ccdcw2020.017

[13] Dong L, Zhou J, Niu C, et al. Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR. Talanta. 2021;224:121726. DOI: 10.1016/j.talanta.2020.121726

[14] Dong L., Zhou J., Niu C., et al. Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR // Talanta. 2021. Vol. 224. P. 121726. DOI: 10.1016/j.talanta.2020.121726

RIGHTS & PERMISSIONS

Eco-Vector